FIELD: medicine.
SUBSTANCE: present invention relates to medicine, particularly to a method for treating arterial hypertension in mammals, including humans, and can be used for emergency treatment of acute hypertension conditions, for example, hypertensive crisis. Disclosed method involves the pulmonary administration of aerosol hypotensive preparation in a therapeutically effective amount consisting of calcium antagonist group in nano-sized aerosol form with the particle size of 5-200 nm and their concentration in the range of 103-108 cm-3. Nifedipine or nisoldipin is used as a hypotensive preparation.
EFFECT: technical result: is fast reduction (by 25 %) of blood pressure by inhalation delivery of a drug in the form of nano-sized aerosol, higher efficiency of arterial hypertension treatment due to high bioavailability of used preparations in nano-sized aerosol form and reduction of their therapeutic dose.
1 cl, 7 dwg, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION AND METHOD FOR PULMONARY ADMINISTRATION THEREOF | 2010 |
|
RU2445119C2 |
INTRODUCTION OF ILOPROST IN FORM OF AEROSOL BOLUSES | 2012 |
|
RU2605849C2 |
INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
PHARMACEUTICAL COMPOSITION BASED ON GLUCOCORTICOSTEROID BUDESONIDE AND PHOSPHATIDYLCHOLINE FOR DRY INHALATION | 2019 |
|
RU2730488C1 |
FILLER FOR CAPSULAR INHALER | 2016 |
|
RU2634258C1 |
MEDICINAL AGENT AND METHOD OF REGULATION OF VASCULAR TONUS | 2001 |
|
RU2201255C1 |
MEDICATION FOR ARTERIAL HYPERTENSION AND CARDIAC DYSRHYTHMIA TREATMENT | 2008 |
|
RU2391980C1 |
COMBINATION OF ORGANIC COMPOUNDS | 2003 |
|
RU2324482C2 |
AEROSOL COMBINATION OF SALMETEROL AND FLUTICASONE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2521975C1 |
HYPOTENSIVE COMBINATION OF VALSARTAN AND CALCIUM CHANNEL BLOCKING AGENT | 1999 |
|
RU2243768C2 |
Authors
Dates
2016-07-27—Published
2014-12-15—Filed